Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/6249

3'-Azido-3'-deoxythymidine (AIDS): Target Organs and Levels of Evidence for TR-469

Toxicology and Carcinogenesis Studies of AZT (CASRN 30516-87-1) and AZT/ a-Interferon A/D B6C3F1 Mice (Gavage Studies)

Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
3'-Azido-3'-deoxythymidine (AIDS)
30516-87-1
12/11/1996 Gavage
MICE ONLY: 0, 30, 60, OR 120 MG/KG; 50/SEX
Southern Research Institute

Levels of Evidence

Male Mice: Equivocal Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Kidney Tubular Cell: ADENOMA 0/50 0/48 0/49 3/50 OR CARCINOMA 0/50 0/48 0/49 1/50 COMBINED 0/50 0/48 0/49 4/50
  • Harderian Gland: ADENOMA 3/33 2/50 2/50 10/46 OR CARCINOMA 0/33 3/50 2/50 0/46 COMBINED 3/33 5/50 2/50 10/46
Female Mice: Clear Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Vagina: SQUAMOUS CELL CARCINOMA 0/50 0/50 5/50 9/50; SQUAMOUS CELL PAPILLOMA OR CARCINOMA 0/50 0/50 5/50 11/50
Non-Neoplastic Lesions
  • Vagina: EPITHELIAL HYPERPLASIA


Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
Interferon AD (AIDS Initiative)
INTERFERONAD
12/11/1996 Subcutaneous Injection
MICE ONLY: 500 OR 5000 UNITS 3X/WEEK; 50/SEX/GROUP
Southern Research Institute

Levels of Evidence: None



Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
Interferon AD + 3'-azido-3'-deoxythymidine (AIDS Initiative)
INTAZTCOMB
12/11/1996 Subcutaneous Injection and Gavage
DUAL ROUTES WITH BOTH COMPOUNDS: AZT: 0, 30, 60, OR 120 (GAV) MG/KG; IFN: 500 OR 5000 UNITS 3X/WEEK
Southern Research Institute

Levels of Evidence: None



Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
Interferon A (AIDS Initiative)
76543-88-9
12/11/1996 Subcutaneous Injection
5000 UNITS 3X A WEEK; 50/SEX/GROUP
Southern Research Institute

Levels of Evidence: None